Canada markets close in 3 hours 40 minutes

Statera Biopharma, Inc. (7CB.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
2.61000.0000 (0.00%)
As of 09:08AM CEST. Market open.
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-91,833
-101,851
-12,094
-3,224
Depreciation & amortization
556.31
255.574
0.947
0
Stock based compensation
201.138
6,060
2,700
-
Change in working capital
13,767
1,066
-51.041
1,109
Accounts receivable
-382.571
-352.092
0
-
Other working capital
-12,194
-28,376
-5,092
-240.37
Other non-cash items
-2,359
-1,301
4,362
1,875
Net cash provided by operating activites
-12,091
-28,193
-5,082
-240.37
Cash flows from investing activities
Investments in property, plant and equipment
-103.367
-182.97
-9.637
-
Net cash used for investing activites
-103.366
13,463
-9.637
0
Cash flows from financing activities
Debt repayment
-10,104
-897.737
0
-
Common stock issued
8,064
7,344
1,346
-
Other financing activites
142.121
-129.26
-61.6
-
Net cash used privided by (used for) financing activities
-1,597
20,988
5,684
231
Net change in cash
-13,710
6,251
592.219
-9.37
Cash at beginning of period
14,216
593.869
1.65
11.02
Cash at end of period
424.656
6,845
593.869
1.65
Free Cash Flow
Operating Cash Flow
-12,091
-28,193
-5,082
-240.37
Capital Expenditure
-103.367
-182.97
-9.637
-
Free Cash Flow
-12,194
-28,376
-5,092
-240.37